April 2023 – The U.S. Food and Drug Administration (FDA) today approved Qalsody (tofersen) for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene. This approval brings…
China’s National Drug Administration (NMPA) has officially approved the marketing application for the novel anti-hepatitis B virus drug Pradefovir Mesylate. This breakthrough provides a new treatment option for patients with chronic hepatitis B (HBV), marking…
In this blog, DengYue will explore the following aspects of Alkindi Hydrocortisone: Advantages over traditional hydrocortisone formulations. . Introduction Alkindi Hydrocortisone is a pediatric-friendly formulation of hydrocortisone used to manage adrenal insufficiency, particularly in children.…
In October 2021, the U.S. Food and Drug Administration (FDA) approved a novel drug, Tavneos (avacopan), for the treatment of ANCA-associated vasculitis (AAV), news that brings new treatment options to patients suffering from this rare…
What is Agamree (Vamorolone)? Agamree Vamorolone, also known by its generic name Vamorolone, is a corticosteroid-like drug primarily used for treating Duchenne muscular dystrophy (DMD). Unlike traditional steroids, Agamree is designed to retain anti-inflammatory benefits…
Parkinson’s Disease (PD) is a complex neurodegenerative disease that affects the quality of life of millions of patients worldwide. In recent years, as medical research continues to deepen, the emergence of a new drug, Xadago…
Introduction Izervay (Avacincaptad Pegol) is a groundbreaking treatment approved for geographic atrophy (GA), an advanced stage of age-related macular degeneration (AMD). GA is a leading cause of vision loss in older adults, with no prior…
Leqembi was recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) in November 2024 for the treatment of early-stage Alzheimer’s disease, targeting patients with mild cognitive impairment…
What is Sulbactam-Durlobactam? Sulbactam Durlobactam is a new and special drug combination used to combat multidrug-resistant infections, particularly those caused by Acinetobacter baumannii-calcoaceticus complex, a serious and often difficult-to-treat pathogen. This combination of Sulbactam and…
On October 15, 2023, the U.S. Food and Drug Administration (FDA) officially approved Enlonstobart Injection (development code: ENL-001) for the treatment of a rare genetic disorder, Idiopathic Fibrotic Syndrome (IFS). This groundbreaking therapy marks another…
The U.S. Food and Drug Administration (FDA) recently announced the approval of Besremi (generic name: ropeginterferon alfa-2b-njft) for the treatment of true erythrocytosis (Polycythemia Vera, PV). This decision marks Besremi as the first FDA-approved interferon…
UCB has recently announced that its innovative therapy, Bimzelx (generic name: bimekizumab-bkzx), has received approval from the U.S. Food and Drug Administration (FDA) for multiple new indications, solidifying its role in treating various immune-mediated inflammatory…
